Insulet appoints technology veteran Jonathan J. Mazelsky to Board of Directors, effective July 1, 2026.

{
  "signal_id": "994a4172-cb78-4b2e-ad6c-a86904fd3d35",
  "signal_type": "sec-8k",
  "signal_subtype": "restructuring",
  "detected_at": "2026-06-30T07:06:11.942+00:00",
  "company": {
    "name": "Insulet",
    "domain": "insulet.com"
  },
  "data": {
    "detail": "The appointment of a new director with extensive experience in healthcare technology (Philips, Agilent) and CEO-level leadership may signal a shift in corporate strategy. High-level leadership changes often trigger reviews of strategic initiatives and key vendor relationships within 90 days.",
    "metrics": {
      "timeframe": "immediate"
    },
    "summary": "Insulet appoints technology veteran Jonathan J. Mazelsky to Board of Directors, effective July 1, 2026.",
    "excerpts": "On June 24, 2026, the Board of Directors (the \"Board\") of Insulet Corporation (the \"Company\") appointed Jonathan J. Mazelsky as a Class II director, effective July 1, 2026.",
    "relevance": 0.9,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1145197/000114519726000148/podd-20260624.htm",
    "filing_date": "2026-06-25",
    "filing_year": 2026,
    "fiscal_year_end": "06/24",
    "sales_relevance": "Change management needs",
    "signal_category": "workforce",
    "regions_mentioned": [
      "North America"
    ],
    "vendors_mentioned": [
      "IDEXX Laboratories, Inc.",
      "Philips Healthcare",
      "Royal Philips",
      "Agilent Technologies",
      "Hewlett Packard",
      "Dentsply Sirona Inc."
    ]
  }
}

curl https://signals.autobound.ai/v1/signals/994a4172-cb78-4b2e-ad6c-a86904fd3d35 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"insulet.com","limit":20}'